DiaMedica Therapeutics Income Tax

DiaMedica Therapeutics (DMAC) currently reports a income tax of $16K as of June 2026. That compares with $14K in the prior-year period — up 14.3% year over year. Use the charts on this page to explore DiaMedica Therapeutics's income tax history and peer comparisons.

DiaMedica Therapeutics's income tax increased from $14K to $16K — a 14.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DiaMedica Therapeutics reported $16K in income tax as of June 2026. That compares with $14K in the prior-year period — up 14.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $16K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DiaMedica Therapeutics, and consider following DMAC for alerts when major investors trade the stock.

DiaMedica Therapeutics is classified in the Healthcare sector. On income tax, it currently shows $16K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMAC with unrelated industries.